Blueberry Therapeutics Ltd - Company Review
SummaryBlueberry Therapeutics Ltd - Company Review
Summary
Blueberry Therapeutics Ltd (Blueberry Therapeutics) is a healthcare products provider that develops therapeutic products. The company develops novel therapies to treat onychomycosis. Its pipeline product portfolio includes BB2603-NCE, developed to treat onychomycosis and associated tinea pedis; BB2312 used for the treatment of Acne diseases, BB5000-NBE, to treat antimicrobial resistance, BB0109-NME developed for the treatment of inflammatory bowel disease and BB2702- NME used to treat atopic dermatitis. Blueberry Therapeutics offers peptides, protein and small molecules to treat infections. The company utilizes drug delivery system based on a nanopolymer that self assembles with small and large molecules and packages them into nanoparticles. It operates through other pharmaceutical companies to develop new drug products. Blueberry Therapeutics is headquartered in Cheshire, the UK.
This comprehensive company report of Blueberry Therapeutics Ltd provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.